Results 101 to 110 of about 48,475 (244)

Pamidronate for Early-Stage, Untreated Myeloma [PDF]

, 2003
Pellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, Carlo Bodenizza, Angelo Michele Carella   +4 more
openalex   +1 more source

P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO [PDF]

, 2013
MM Kostik, L. A. Vasyakina, Ponomarenko Vm, I. Chikova, А А Минкин, О. В. Калашникова, IV Shvedovchenko, VG Chasnyk   +7 more
openalex   +1 more source

Adjuvant pamidronate therapy prevents the development of bone metastases in breast cancer patients with four or more positive nodes

, 2010
Ikuo Kokufu, Norio Kohno, Masayuki Yamamoto, Shintaro Takao   +3 more
openalex   +2 more sources

Chronic Recurrent Multifocal Osteomyelitis (CRMO): four cases treated with aminobisphosphonate (pamidronate) [PDF]

, 2008
B. Teruzzi, Anita Salmaso, V. Gerloni, M. Gattinara, Irene Pontikaki, F Fantini   +5 more
openalex   +1 more source

The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta

The Turkish Journal of Pediatrics, 2004
Over the past 20 years, orally administered biphosphonates have been used extensively in the management of a number of common skeletal disorders of different etiology.
Pelin Adiyaman, Gönül Ocal, Merih Berberoğlu, Olcay Evliyaoğlu, Zehra Aycan, Ergun Cetinkaya   +5 more
doaj  

Analysis of Series of Cases of Fibrous Dysplasia of Proximal Femur in Pediatric Population

Journal of Orthopaedic Case Reports
Introduction: Fibrous dysplasia (FD) accounts for 5–7% of all benign bone tumors. It presents in two main forms – monostotic, which is more common affecting a single bone and presenting usually in 3rd decade of life; polyostotic, affecting several bones,
Sumit Gupta, Ankur Agarwal, Lokesh Raghav, Shray Jain, Amit Kumar Gupta   +4 more
doaj   +1 more source

The calibration and validation of the integrated computational models with pamidronate and denosumab.

, 2012
(a) The calibration of the integrated model with denosumab according to the NTX levels. (b) The validation of the integrated model with denosumab according to the CTX levels.
Yan Wang (15435), Bo Lin (116835)
core   +1 more source

Response to alendronate in osteoporotic women previously treated with pamidronate

, 2003
INTRODUCTION: Different bisphosphonates have been shown to increase bone mineral density (BMD) and reduce the risk of fracture in osteoporotic patients.
Fuss, Michel, Fellemans, C., Bergmann, Pierre, Rozenberg, Serge, Siderova, Vania, Peretz, Anne, Body, Jean-Jacques, Dumon, Jean Claude   +7 more
core  

The Effect of Locally Administered Pamidronate on Autogenous Bone Graft in Maxillofacial Reconstruction: A Randomized Clinical Trial

International Journal of Organ Transplantation Medicine, 2017
Background: Although bone grafts are commonly used in reconstructive surgeries, they are sensitive to local perfusion and are thus prone to severe resorption.
M Bayat, A Garajei, E Afshari Pour, M Hasheminasab, Y Ghorbani, MH Kalantar Motamedi, N Bahrami   +6 more
doaj  

Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.

, 2001
Collapsing focal segmental glomerulosclerosis (FSGS) is a distinct clinicopathologic entity seen most commonly in young African American patients who present with renal insufficiency and nephrotic syndrome. The only epidemiologic factor previously linked
Markowitz, Glen S, Kuhn, Joseph A, Dratch, Adam D, D\u27Agati, Vivette D, Appel, Gerald B, Fine, Paul L, Fenves, Andrew Z, Loon, Nicholas R, Jagannath, Sundar   +8 more
core